TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+11.16%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$1.09B
AUM Growth
+$1.09B
(+8.9%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
54.62%
Holding
69
New
7
Increased
13
Reduced
10
Closed
5
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$40.5M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$14.1M |
| 3 |
Incyte
INCY
|
$11.9M |
| 4 |
Pfizer
PFE
|
$9.94M |
| 5 |
Bristol-Myers Squibb
BMY
|
$9.83M |
Top Sells
| 1 |
Puma Biotechnology
PBYI
|
$19.4M |
| 2 |
Perrigo
PRGO
|
$15.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$10.1M |
| 4 |
iShares Biotechnology ETF
IBB
|
$9.48M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$7.6M |
Sector Composition
| 1 | Healthcare | 88.61% |
| 2 | Financials | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $125M | 11.45% | 1,504,712 | – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $81.1M | 7.44% | 944,092 +472,046 | +100% | +$40.5M |
|
3
Biogen
BIIB
$19.4B
| $54.9M | 5.04% | 173,983 | – | – |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $54.6M | 5.02% | 193,466 -17,700 | -8% | -$5M |
|
5
Amgen
AMGN
$155B
| $53.2M | 4.88% | 449,543 | – | – |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $52.5M | 4.82% | 335,899 | – | – |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $51.2M | 4.7% | 540,944 +41,180 | +8% | +$3.9M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $45.9M | 4.21% | 205,707 | – | – |
|
|
9
Incyte
INCY
$16.5B
| $43.4M | 3.98% | 768,238 +210,158 | +38% | +$11.9M |
|
10
Viatris
VTRS
$12.3B
| $33.6M | 3.09% | 652,209 | – | – |
|
|
SHPG
11
DELISTED
Shire pic
SHPG
| $29M | 2.67% | 123,322 -30,831 | -20% | -$7.26M |
|
|
AGN
12
DELISTED
ALLERGAN INC
AGN
| $26.5M | 2.43% | 156,627 -59,710 | -28% | -$10.1M |
|
13
BioMarin Pharmaceuticals
BMRN
$11.2B
| $26.2M | 2.41% | 421,384 | – | – |
|
|
AKRX
14
DELISTED
Akorn, Inc.
AKRX
| $23.3M | 2.13% | 699,382 | – | – |
|
|
AET
15
DELISTED
Aetna Inc
AET
| $20.1M | 1.84% | 247,541 +700 | +0.3% | +$56.8K |
|
16
Illumina
ILMN
$15.8B
| $18.5M | 1.7% | 103,841 | – | – |
|
|
CBST
17
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $18.4M | 1.69% | 263,772 +37,000 | +16% | +$2.58M |
|
|
18
iShares Biotechnology ETF
IBB
$5.6B
| $16.8M | 1.54% | 65,184 -36,896 | -36% | -$9.48M |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $16.3M | 1.5% | 311,476 | – | – |
|
|
20
Jazz Pharmaceuticals
JAZZ
$7.75B
| $14.1M | 1.29% | +95,957 | New | +$14.1M |
|
|
EIGR
21
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $13.2M | 1.21% | 970,495 | – | – |
|
22
Alkermes
ALKS
$4.78B
| $12.9M | 1.18% | 255,970 +61,100 | +31% | +$3.08M |
|
23
McKesson
MCK
$85.4B
| $12.6M | 1.16% | 67,862 | – | – |
|
24
Ironwood Pharmaceuticals
IRWD
$214M
| $11.8M | 1.08% | 768,050 | – | – |
|
25
Neurocrine Biosciences
NBIX
$13.8B
| $11.7M | 1.08% | 790,490 +362,700 | +85% | +$5.38M |
|